Henry Schein reported its financial reports for the second quarter this year, ending June 25.
Here are six takeaways:
1. The company had dental sales hitting $1.4 billion, up 4 percent from the same period of 2015.
2. Of the company's dental sales, there was 4.1 percent growth in local currencies and a 0.1 percent drop in the foreign currency exchange. North America had a 2 percent growth in local currencies.
3. The company had net sales hitting $2.9 billion, a 9.3 percent increase from the second period the year prior.
4. Net income attributable to Henry Schein was $120.1 million, or $1.46 per share. Income growth is due to a favorable proposed tax audit settlement that led to a $4.5 million reduction in income tax expenses.
5. Net sales hit $5.6 billion during the first half of 2016, ending June 15, up 9.7 percent from the first half of 2015.
6. The company expects adjusted diluted earnings per share between $6.55 and $6.66 for 2016.
"North America dental sales were below our expectations in the second quarter, however, sales in our medical, animal health and technology and value-added services businesses were strong," said Stanley M. Bergman, board chairman and CEO, Henry Schein. "Our business model has served us well during periods of sustained economic expansion as well as in times of uncertainty in our markets. We believe our business model and strategic plan, including our continued investments, will drive our growth over the long term and we remain extremely well-positioned in each of the vertical markets we serve."
More dental news:
Danaher revenue totals $5.8B in Q2, Biolase operating margin totals 41% & more — 5 key notes
5 things to know about virtual dental homes
Carolina Family Health Center adds Dr. Hilary Patterson: 3 notes